...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Top-Line Data Expected September 2019 for BETonMACE Phase 3 Cardiovascular Outcomes Trial for Apabetalone

Free
Message: RESVERLOGIX ANNOUNCES. $15.1 MILLION OF PRIVATE PLACEMENTS

Thanks for posting. Just be sure if you are the first to post a news release, please choose the "Press Release" option instead of the default "Message" so that it shows up in the Agoracom news feed. I just re-posted it this way....that's why I posted the news release again.

BearDownAZ

Share
New Message
Please login to post a reply